Gujarat Inject Kerala Ltd Appoints Dipak Diwan as CFO for 5-Year Term, Strengthens Financial Leadership

Gujarat Inject Kerala Ltd (GIKL), a public-listed pharmaceutical and chemical company based in Palakkad, Kerala, has announced the appointment of Dipak Diwan as its new Chief Financial Officer (CFO) for a fixed tenure of five years. The decision was approved by the company’s Board of Directors as part of its ongoing efforts to bolster strategic financial oversight and governance.

 

Dipak Diwan brings with him over two decades of experience in corporate finance, compliance, and capital structuring across manufacturing and healthcare sectors. His appointment is expected to enhance GIKL’s financial planning, investor relations, and regulatory alignment as the company navigates its next phase of growth.

 

The move comes at a time when GIKL is actively pursuing operational expansion and exploring new product lines in specialty chemicals and formulations. The company has also recently executed an investment sale agreement with Soleos Energy Pvt Ltd, signaling a broader diversification strategy.

 

Key Highlights:

With this leadership change, GIKL aims to reinforce its financial backbone and drive sustainable value creation for stakeholders.

 

Source: Business Standard, Economic Times Markets, The Company Check